A carregar...

Evacetrapib Reduces Preβ-1 HDL in Patients with Atherosclerotic Cardiovascular Disease or Diabetes

BACKGROUND AND AIMS: To investigate the effect of cholesteryl ester transfer protein (CETP) inhibitor on subclasses of HDL in patients with atherosclerotic cardiovascular disease or diabetes. CETP inhibitor-mediated a dramatic induction of HDL-cholesterol has no effect on the protection of cardiovas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Atherosclerosis
Main Authors: Chen, Yunqin, Dong, Jibin, Zhang, Xiaojin, Chen, Xueying, Wang, Li, Chen, Haozhu, Ge, Junbo, Jiang, Xian-Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548311/
https://ncbi.nlm.nih.gov/pubmed/31054484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2019.04.211
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!